This research study is currently not recruiting patients.

Have you been diagnosed with Parkinson's Disesase but do not take medication?

What is the purpose of this study?

This study is to see if Cogane will improve or slow down the symptoms of Parkinson's disease.

Can I participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:Early Parkinson's disease, Parkinson's disease.
  • Age: Between 35 - 75 Years
  • Gender: Male or Female
  • Inclusion Criteria:
  • Exclusion Criteria:

Detail Study Description

This study tests the effects of Cogane compared to placebo (a lookalike pill containing no medicine) on the progression of your Parkinson's Disease. This study is to see if Cogane will improve or slow down the symptoms of Parkinson's disease.

Study Treatments

Source: ClinicalTrials.gov
Clinical Study Identifier: TX1927
Last Updated: December 2011

Do you want to learn more about the study?

1. Enter Your Email:

2. Enter Your Name (optional):

2. Enter Your Phone Number(optional):

3. Preview Your Message

To: Research Study Investigator
Subject: I am interested in participating in your Research Study
Dear Investigator,
I'm interested in learning more about and participating in your research study named: A Phase II, multi-centre, randomised, double-blind, placebo-controlled, parallel group study to investigate the efficacy, safety and tolerability of Cogane™ (PYM50028), a novel, orally active neurotrophic factor inducer, in male and female subjects with early-stage Parkinson’s disease when administered once daily for 28 weeks.
I am hoping to hear back from you and discuss details of the study

Contact Investigators

(All your information is sent securely)

Why Contact Clinical Trial Investigator?

From: TrialX
To: Clinical Trial Investigator
Subject: I am interested in participating in your Clinical Trial
Dear Investigator,

I'm interested in learning more about and participating in your clinical trial named:

A Phase II, multi-centre, randomised, double-blind, placebo-controlled, parallel group study to investigate the efficacy, safety and tolerability of Cogane™ (PYM50028), a novel, orally active neurotrophic factor inducer, in male and female subjects with early-stage Parkinson’s disease when administered once daily for 28 weeks.

I am hoping to hear back from you and discuss details of the trial


Username:
Password:
    

Forgot your login or password?

Create your Account

Name:
Email:
Username:
Password:
Retype Password:
State:
Address:
(Optional)
City: Zip:
By creating an account, you accept our Terms of Service

Why create an account on TrialX?

You can use the following additional services that are not available to unregistered users
  • Set up email alerts for matching clinical trials
  • Save selected clinical trials for later review
  • Connect your Trialx.org account with other Personal Health Record services

The Cleveland Clinic © 1995-2010. All Rights Reserved. 9500 Euclid Avenue, Cleveland, Ohio 44195 | 800.223.2273 | TTY 216.444.0261